Company Filing History:
Years Active: 2016
Title: Innovations of Gregor Macdonald in Neurological Research
Introduction
Gregor Macdonald is an accomplished inventor based in Beerse, Belgium. He has made significant contributions to the field of neurological research through his innovative work on receptor modulators. His expertise and dedication have led to advancements that may improve treatments for various neurological and psychiatric disorders.
Latest Patents
Gregor Macdonald holds a patent for "Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulators." This invention relates to substituted pyrazolo[1,5-a]pyrazines analogs and derivatives, which serve as positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5). The patent outlines synthetic methods for creating these compounds, pharmaceutical compositions that include them, and methods for treating neurological and psychiatric disorders associated with glutamate dysfunction.
Career Highlights
Macdonald's career is marked by his role at Vanderbilt University, where he has been instrumental in advancing research in the field of pharmacology. His work has not only contributed to academic knowledge but also holds potential for real-world applications in medicine.
Collaborations
Some of his notable coworkers include P Jeffrey Conn and Craig William Lindsley. Their collaborative efforts have further enhanced the impact of their research in the scientific community.
Conclusion
Gregor Macdonald's innovative work in receptor modulation represents a significant step forward in the treatment of neurological disorders. His contributions continue to inspire advancements in medical research and therapeutic development.